JMP Securities Upgrades Myriad Genetics To Outperform By: Benzinga via Benzinga February 04, 2015 at 07:43 AM EST Analysts at JMP Securities upgraded Myriad Genetics Inc. (NASDAQ: MYGN) from Market Perform to Market Outperform. The price target ... Read More >> Related Stocks: Myriad Genetics Inc